There were no statistically significant differences in the clinical characteristics of the breast cancers between variant carriers and non-carriers by age at diagnosis, estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) status, tumor histology, size, and lymph node involvement. This evidence concerns the gene ESR1 and breast cancer.